Connor Clark & Lunn Investment Management Ltd. Increases Position in KORU Medical Systems, Inc. (NASDAQ:KRMD)

Connor Clark & Lunn Investment Management Ltd. increased its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) by 77.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 61,412 shares of the company’s stock after purchasing an additional 26,860 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned 0.13% of KORU Medical Systems worth $168,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of KRMD. Meros Investment Management LP increased its stake in KORU Medical Systems by 20.7% in the 2nd quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock worth $2,132,000 after buying an additional 137,918 shares in the last quarter. Vanguard Group Inc. raised its stake in KORU Medical Systems by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 1,961,764 shares of the company’s stock valued at $4,630,000 after purchasing an additional 51,890 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in KORU Medical Systems in the 2nd quarter worth approximately $107,000. Virtu Financial LLC bought a new position in KORU Medical Systems in the 1st quarter worth approximately $63,000. Finally, Legato Capital Management LLC purchased a new stake in KORU Medical Systems during the 2nd quarter valued at approximately $35,000. Hedge funds and other institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Price Performance

KORU Medical Systems stock opened at $3.98 on Monday. KORU Medical Systems, Inc. has a 52-week low of $1.98 and a 52-week high of $4.10. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. The firm’s fifty day moving average is $2.90 and its 200 day moving average is $2.58. The company has a market cap of $182.43 million, a price-to-earnings ratio of -15.92 and a beta of 0.41.

Wall Street Analyst Weigh In

KRMD has been the subject of a number of research reports. Canaccord Genuity Group upped their target price on shares of KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Craig Hallum boosted their price target on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Finally, Piper Sandler raised their price objective on KORU Medical Systems from $3.00 to $3.50 and gave the company an “overweight” rating in a research report on Thursday, November 14th.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.